Sort
30,917 grants matching “tumor microenvironment”
A framework for integrating MR imaging and clinical tests for prediction of outcomes in multiple myeloma treatment
$570,314Chuan Zhou · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Study interactions between lung microbiota and immune cells in NSCLC
$570,287Chen Zhao · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Identifying oral cancer stem cell properties affected by the microenvironment
$570,269Xiao-Jing Wang · University Of Colorado Denver · R01 · FY2017 · DE
Mechanistic insights on structure, topology and radiation effects on RNA nanomedicines
$570,260Conroy Ghin Chee Sun · Oregon State University · R01 · FY2023 · CA
Role of inflammation in epigenetic alterations of metastatic cancer cells
$570,247Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
$570,235Catherine C Park · University Of California, San Francisco · R01 · FY2018 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
$570,144Mary L. Disis · University Of Washington · R01 · FY2014 · CA
PD-1/PD-L1 modulation in cancer therapy
$570,133Drew M. Pardoll · Johns Hopkins University · R01 · FY2024 · CA
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment
$570,048Ruogang Zhao · State University Of New York At Buffalo · R01 · FY2024 · CA
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
$570,047Randolph J. Noelle · Dartmouth College · R01 · FY2018 · CA
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
$570,047Randolph J. Noelle · Dartmouth College · R01 · FY2017 · CA
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
$570,047Randolph J. Noelle · Dartmouth College · R01 · FY2021 · CA
Targeting VISTA eradicates large, established PD-1/CTLA-4 resistant tumors
$570,047Randolph J. Noelle · Dartmouth College · R01 · FY2020 · CA
Microenvironmental Control of Capillary Morphogenesis
$570,046Andrew J Putnam · University Of Michigan At Ann Arbor · R01 · FY2021 · HL
The Role of Kaiso as a predictive breast cancer biomarker in Africa and across the African Diaspora
$569,880Kevin L. Gardner · Columbia University Health Sciences · R01 · FY2024 · CA
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$569,842John H Sampson · Duke University · U01 · FY2015 · NS
Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity
$569,782Russell William Jenkins · Medical University Of South Carolina · R37 · FY2025 · CA
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
$569,704Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Regulation of anti-tumor immunity by HDAC11
$569,672Edward Seto · George Washington University · R01 · FY2022 · CA
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
$569,509William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
$569,443Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation
$569,430Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment
$569,405Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing
$569,391Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
$569,381Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA